← FDA Drug Approvals (Drugs@FDA)
NAPROXEN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ONESOURCE SPECIALTY · Approved 2022-08-17
Drug application
- FDA Application #
ANDA215472- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN SODIUM
- Generic name
- Naproxen Sodium
- Active ingredients
- NAPROXEN SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ONESOURCE SPECIALTY
- First approval
- 2022-08-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown